Wird geladen...
Dexmedetomidine for the management of awake fibreoptic intubation
BACKGROUND: Awake fibreoptic intubation (AFOI) frequently requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function. The goal is to allow the patient to be responsive and co‐operative. Medications such as fentanyl, remifentanil, midaz...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2014
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095023/ https://ncbi.nlm.nih.gov/pubmed/24442817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009798.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|